Retinal microvascular function predicts chronic kidney disease in patients with cardiovascular risk factors

James D Theuerle1, Ali H Al-Fiadh1, Edmond Wong2

  • 1Department of Cardiology, Austin Health, Melbourne, Australia; Department of Medicine, Austin Health, The University of Melbourne, Melbourne, Australia.

Atherosclerosis
|November 10, 2021
PubMed

Insights

Retinal microvascular dysfunction, indicated by reduced flicker light-induced retinal arteriolar dilatation (FI-RAD), is present in cardiovascular disease patients with early chronic kidney disease (CKD). Lower FI-RAD predicts long-term CKD progression in those with normal renal function.

Area of Science:

  • Ophthalmology
  • Nephrology
  • Cardiology

Background:

  • Endothelial dysfunction links cardiovascular disease (CVD) and chronic kidney disease (CKD).
  • Retinal microvascular changes may indicate systemic vascular health.
  • Investigating retinal dysfunction's role in CKD progression is crucial.

Purpose of the Study:

  • To assess retinal microvascular dysfunction in CVD patients with renal impairment.
  • To determine if retinal microvascular dysfunction predicts long-term CKD progression.

Main Methods:

  • Prospective observational study of 253 CVD patients.
  • Dynamic retinal vessel analysis using flicker light stimulation to measure arteriolar and venular dilatation.
  • Serial assessment of estimated glomerular filtration rate (eGFR) over a median of 9.3 years.

Main Results:

  • Reduced flicker light-induced retinal arteriolar dilatation (FI-RAD) was observed in patients with baseline eGFR <90 mL/min/1.73 m².
  • In patients with normal renal function, lower FI-RAD responses correlated with a greater annual decline in eGFR.
  • A 1% decrease in FI-RAD was associated with accelerated eGFR decline (0.07-0.10 mL/min/1.73 m²/year) in those with normal renal function.

Conclusions:

  • Retinal arteriolar endothelial dysfunction is present in CVD patients with early-stage CKD.
  • FI-RAD serves as a predictor of long-term CKD progression in CVD patients with normal baseline renal function.
  • Retinal vessel analysis may offer insights into CKD progression risk.
Abstract

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
149
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
149
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
193
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
107
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
27
Renal Corpuscle01:20

Renal Corpuscle

The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
3.8K